- Demographic characteristics of the patients (N=73).
| Characteristics | n (%) |
|---|---|
| Gender | |
| Male | 56 (76.7) |
| Female | 17 (23.3) |
| Age | |
| Mean±SD | 66,49±11,75 |
| Min-max (median) | 43-91 (67) |
| Presence of comorbidities | |
| No | 40 (54.8) |
| Yes | 33 (45.2) |
| Tumor localization | |
| Cardia | 3 (4.1) |
| Corpus | 16 (21.91) |
| Big curvature | 9 (12.32) |
| Small curvature | 14 (19.17) |
| Antrum | 30 (41.09) |
| Pylorus | 1 (1.36) |
| Surgery technique | |
| Subtotal gastectomy+D2 lymph node dissection | 42 (57.5) |
| Total gastrectomy + D2 lymph node dissection | 31 (42.5) |
| Additional organ resection | |
| Cholecystectomy | 8 (10.95) |
| Splenectomy | 4 (5.47) |
| Pathology | |
| Well differentiated adenocarcinoma | 2 (2.73) |
| Moderately differentiated adenocarcinoma | 22 (30.13) |
| Poorly differentiated adenocarcinoma | 37 (50.68) |
| Signet ring cell | 5 (6.84) |
| Mucinous adenocarcinoma | 6 (8.21) |
| Adenosquamous carcinoma | 1 (1.36) |
| Complication | |
| Wound site infection | 4 (5.47) |
| Pulmonary embolism | 1 (1.36) |
| Pneumonia | 3 (4.1) |
| Pleural effusion | 1 (1.36) |
| Hospitalization period (days) | |
| Mean±SD | 10,11±4,77 |
| Min – Max (median) | 7 -40 (9) |
| Adjuvant chemotherapy | 62 (84.9%) |
| Total number of lymph nodes | |
| Mean±SD | 21,29±11,59 |
| Min-max (median) | 4-56 (19) |
| Number of metastatic lymph nodes | |
| Mean±SD | 7,63±9,56 |
| Min-max (median) | 0-44 (5) |
| N-ratio | |
| Mean±SD | 0,32±0,31 (0,25) |
| Min-max (median) | |
| Follow-up (month) | |
| Mean±SD | 19,38±15,84 |
| Min-max (median) | 1 – 61 (14) |
| Mortality | 23 (31.5%) |
| Average estimated survival time (months) | 40.921 |
Values are presented as number and percentages (%). SD: standard deviation